2m 2m 2m 2m 2m 2m 2m
Natl Health REIT (NHI)
NYSE
$69.55+$0.01 (+0.02%)
Price as of Jun 03, 2026 7:59 PM EDT- $3.7BMarket Cap
- 2.69%1-Year Change
- REIT - Healthcare FacilitiesIndustry
Natl Health REIT (NHI)
$69.55+$0.01 (+0.02%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 375.6M +12.07% | 335.2M +4.80% | 319.8M +14.97% | 278.2M -6.87% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 375.6M +12.07% | 335.2M +4.80% | 319.8M +14.97% | 278.2M -6.87% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 80.9M +13.30% | 71.4M +2.10% | 70.0M -1.28% | 70.9M -12.28% | |
Total Operating Expenses | 239.0M +12.78% | 211.9M +5.48% | 200.9M -16.94% | 241.9M +11.90% | |
Operating Profit | 142.2M +3.04% | 138.0M +1.72% | 135.7M +104.29% | 66.4M -40.61% | |
Interest Income | 0 N/A | 0 -100.00% | 1.8M -92.71% | 24.7M -10.73% | |
Interest Expense | -57.4M -4.23% | -59.9M +3.00% | -58.2M +29.48% | -44.9M -11.60% | |
Interest Income and Expense and Net | -57.4M -4.23% | -59.9M +6.29% | -56.4M +178.75% | -20.2M -12.64% | |
Total Nonoperating Income and Expense | 0 N/A | 0 -100.00% | 58.2M N/A | 0 -100.00% | |
Income before Taxes | 142.0M +2.98% | 137.9M +1.67% | 135.6M +104.20% | 66.4M -40.61% | |
Income Taxes | 200,000 +100.00% | 100,000 0.00% | 100,000 0.00% | 100,000 0.00% | |
Extraordinary Items | 912,000 -93.17% | 13.4M -54.64% | 29.4M -48.06% | 56.7M -12.79% | |
Net Income | 142.2M +3.04% | 138.0M +1.72% | 135.7M +104.29% | 66.4M -40.61% | |
Net Income from Continuing Operations Applicable to Common | 142.0M +2.98% | 137.9M +1.67% | 135.6M +104.20% | 66.4M -40.61% | |
Basic EPS and Net Income | 3.03 -3.50% | 3.14 +0.32% | 3.13 +111.49% | 1.48 -39.59% | |
Diluted EPS and Net Income | 3.02 -3.51% | 3.13 0.00% | 3.13 +111.49% | 1.48 -39.34% | |
Basic Weighted Average Shares | 46.9M +6.91% | 43.8M +1.05% | 43.4M -3.10% | 44.8M -2.06% | |
Diluted Weighted Average Shares | 47.1M +6.69% | 44.1M +1.64% | 43.4M -3.14% | 44.8M -2.05% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 19.6M -19.21% | 24.3M +8.69% | 22.3M +15.84% | 19.3M -48.44% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 19.6M -19.21% | 24.3M +8.69% | 22.3M +15.84% | 19.3M -48.44% | |
Total Current Assets | 17.8M -21.96% | 22.8M -5.44% | 24.1M +24.74% | 19.3M -48.44% | |
Accumulated Depreciation | 822.0M +10.74% | 742.3M +10.25% | 673.3M +10.07% | 611.7M +6.07% | |
Property and Plant and Equipment and Net | 2.5B +11.87% | 2.2B +4.94% | 2.1B -0.53% | 2.1B -8.61% | |
Total Long-Term Assets | 17.8M -21.96% | 22.8M -5.44% | 24.1M +45.09% | 16.6M -21.16% | |
Total Assets | 2.8B +6.98% | 2.6B +5.06% | 2.5B -0.76% | 2.5B -11.68% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 204.0M -38.41% | 331.2M +35.18% | 245.0M +483.33% | 42.0M N/A | |
Total Current Liabilities | 43.7M +15.83% | 37.8M +10.07% | 34.3M +32.42% | 25.9M +11.75% | |
Total Long-Term Debt | 1.2B +1.55% | 1.1B +0.97% | 1.1B -1.09% | 1.1B -7.67% | |
Total Long-Term Liabilities | 201.7M +226.45% | 61.8M -0.03% | 61.8M +2.84% | 60.1M N/A | |
Total Liabilities | 1.3B +2.26% | 1.2B +1.22% | 1.2B -0.25% | 1.2B -7.90% | |
Retained Earnings | 2.7B +5.46% | 2.6B +5.59% | 2.5B +848.35% | -329.6M N/A | |
Total Stockholders Equity | 1.5B +11.35% | 1.4B +8.97% | 1.3B -1.28% | 1.3B -15.72% | |
Total Shares Outstanding | 48.3M +5.72% | 45.7M +5.25% | 43.4M +0.05% | 43.4M -5.37% | |
Cash Flow | |||||
Cash from Operating Activities | 236.6M +13.86% | 207.8M +12.64% | 184.4M -0.48% | 185.3M -12.10% | |
Capital Expenditures | 274.1M +98.42% | 138.1M +262.72% | 38.1M +498.38% | 6.4M -86.41% | |
Cash from Investing Activities | -269.1M +39.95% | -192.3M +1,553.61% | -11.6M -105.88% | 197.9M +6.84% | |
Dividends Paid | 169.7M +8.43% | 156.5M +0.17% | 156.2M -3.42% | 161.8M -11.55% | |
Cash from Financing Activities | 25.7M +289.48% | -13.6M -92.01% | -169.7M -57.70% | -401.3M -0.43% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | 37.85% -8.06% | 41.17% -2.94% | 42.41% +77.69% | 23.87% -36.23% | |
Return on Assets | 5.25% -2.83% | 5.41% -0.41% | 5.43% +118.61% | 2.48% -33.80% | |
Return on Equity | 9.85% -6.51% | 10.53% -2.02% | 10.75% +124.78% | 4.78% -35.43% | |
Revenue Growth | 12.07% +151.50% | 4.80% -67.94% | 14.97% +317.89% | -6.87% -32.94% | |
Current Ratio | 0.41 -32.63% | 0.60 -14.10% | 0.70 -5.80% | 0.74 -53.86% | |
Cash Ratio | 0.45 -30.25% | 0.64 -1.24% | 0.65 -12.53% | 0.74 -53.86% | |
Debt-to-Equity Ratio | 0.90 -16.84% | 1.08 -1.77% | 1.10 +17.52% | 0.94 +13.56% | |
Debt-to-Assets Ratio | 0.49 -13.45% | 0.57 +1.88% | 0.55 +16.91% | 0.47 +8.36% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow